ATANIS Biotech AG (Capital increase)
Funding Details
- Awarder
- Inbox
- Date Award
- June 09, 2025
- Vertical
- Biotech
- Funding URL
- View Funding Page
Company Info
- Traction
- ATANIS Biotech serves over 20 institutional clients from pharma, biotech, and agri-food industries, providing services ranging from pre-clinical compound screening to efficacy assessment of selected drug candidates.
- Company Description
- ATANIS Biotech AG specializes in functional allergy diagnosis and has developed a novel, functional ex vivo mast cell activation test named FAST-PASE, which uses shelf-stable patient serum for scalability and has outperformed established clinical methods in diagnostic accuracy.
- Market
- Allergy diagnostics
- Location
- Bern, Bern, Switzerland
- Coinvestors
- Spectrum Moonshot Fund